Salicylic acid protects against the development of Barrett’s esophagus
The use of salicylic acid (ASA) reduces the risk of developing Barrett’s esophagus, which is considered as the main factor affecting the occurrence of esophageal cancer. A study describing the dependence of the ASA use and the development of the Barrett’s esophagus was published in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. Read full text »
Videos
Pictures
Documents










